ALLAN JONATHAN (GENERAL COUNSEL & CORP SEC) sold 25.2% of their position (3.98K shares) of STOKE THERAPEUTICS, INC. on the open market
Open‑market sale worth $128.4K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 12/10/2025ACC: 0001966716-25-000009
Officer· GENERAL COUNSEL & CORP SEC
Since Feb 2026
-3.98K
Net shares
Net seller
$128.4K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
3.98K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−1.30K
Price / share
$31.60
Trade value
$41.07K
% of position
8.2%
12/8/2025
15.81K→14.51K
Common Stock
Direct
Shares
−2.68K
Price / share
$32.61
Trade value
$87.34K
% of position
18.5%
12/8/2025
14.51K→11.83K
Total
Net shares
−3.98K
Net value
-$128.41K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/8/2025 | S · Sale | −1.30K | $31.60 | $41.07K | 8.2% | 15.81K | 14.51K |
| Common Stock Direct | 12/8/2025 | S · Sale | −2.68K | $32.61 | $87.34K | 18.5% | 14.51K | 11.83K |
| Total | −3.98K | -$128.41K | ||||||
Derivative Transactions0
No derivative transactions reported